Literature DB >> 6700544

Incidence of neuroblastoma in infancy in Japan.

T Sawada, T Kidowaki, T Sugimoto, T Kusunoki.   

Abstract

Since 1974, we have been mass screening for neuroblastoma in 6-month-old infants using a VMA (vanilmandelic acid) spot test in Kyoto City. Fifteen (48.4%) of the 31 childhood neuroblastoma cases registered in this city during the recent 8-year-period, 1974-1982, were under 1 year of age. The annual number of cases per year was 3.9 cases under 15 years with 1.9 cases under 1 year of age. As the number of children under 15 years of age in this city was 292,000 according to the National Census of the Human Population in 1975, the annual incidence of this tumor in childhood was 3.9/292,000 (13.3/million). And as the number of live births was 161,153, the annual detection rate for this tumor in infancy increased to 15/161,153 (93/million) from 1974 to 1982. We found that many neuroblastomas could be detected in infancy by a VMA spot test and/or a careful physical examination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6700544     DOI: 10.1002/mpo.2950120208

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

1.  Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.

Authors:  C R Scriver; D Gregory; M Bernstein; C L Clow; T Weisdorf; G E Dougherty; C Auray-Blais; R Giguère; B Lemieux; C Laberge
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

2.  Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.

Authors:  M Nishi; H Miyake; T Takeda; N Takasugi; Y Sato; J Hanai
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

3.  How frequent is spontaneous remission of neuroblastomas? Implications for screening.

Authors:  N L Carlsen
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.